Sarissa Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-262,080
| Closed | -$24.2M | – | 8 |
|
|
2024
Q4 | $24.2M | Sell |
262,080
-501,253
| -66% | -$46.3M | 7.5% | 5 |
|
|
2024
Q3 | $64M | Sell |
763,333
-339,949
| -31% | -$28.5M | 15.91% | 3 |
|
|
2024
Q2 | $75.7M | Hold |
1,103,282
| – | – | 12.78% | 4 |
|
|
2024
Q1 | $80.8M | Buy |
1,103,282
+27,882
| +3% | +$2.04M | 14.14% | 4 |
|
|
2023
Q4 | $87.1M | Buy |
1,075,400
+155,000
| +17% | +$12.6M | 13.43% | 4 |
|
|
2023
Q3 | $69M | Hold |
920,400
| – | – | 9.29% | 5 |
|
|
2023
Q2 | $70.9M | Buy |
920,400
+70,400
| +8% | +$5.43M | 7.06% | 5 |
|
|
2023
Q1 | $70.5M | Sell |
850,000
-218,750
| -20% | -$18.1M | 9.02% | 5 |
|
|
2022
Q4 | $91.8M | Sell |
1,068,750
-204,350
| -16% | -$17.5M | 10.92% | 4 |
|
|
2022
Q3 | $78.5M | Sell |
1,273,100
-68,800
| -5% | -$4.24M | 8.88% | 4 |
|
|
2022
Q2 | $82.9M | Sell |
1,341,900
-221,000
| -14% | -$13.7M | 8.35% | 5 |
|
|
2022
Q1 | $92.9M | Sell |
1,562,900
-1,326,400
| -46% | -$78.9M | 8.78% | 5 |
|
|
2021
Q4 | $210M | Sell |
2,889,300
-78,000
| -3% | -$5.66M | 18.16% | 2 |
|
|
2021
Q3 | $207M | Buy |
2,967,300
+269,900
| +10% | +$18.9M | 16.27% | 3 |
|
|
2021
Q2 | $186M | Hold |
2,697,400
| – | – | 14.77% | 4 |
|
|
2021
Q1 | $174M | Buy |
+2,697,400
| New | +$174M | 16.71% | 3 |
|